In a mixed cohort of ischemic and hemorrhagic stroke patients, raised LCN2 levels in the peripheral blood obtained within 24 hours from symptom onset were associated with 6-month mortality [15]. The gene discussed is LCN2; the disease is hemorrhagic stroke.